| Literature DB >> 28676039 |
J Mahlich1,2, K Matsuoka3, Y Nakamura4, R Sruamsiri5,6.
Abstract
BACKGROUND: Inflammatory Bowel Disease (IBD) constitutes a huge burden for patients and studies show that IBD patients have difficulties remaining in employment. Because there is no data about the unemployment of IBD patients in Japan.Entities:
Keywords: Burden of disease; Inflammatory bowel disease; Japan; Unemployment
Mesh:
Year: 2017 PMID: 28676039 PMCID: PMC5496236 DOI: 10.1186/s12889-017-4516-0
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Definition of variables used
| Type of variable | Type of response | |
|---|---|---|
| Outcome variable | Employment status | Unemployed |
| Employed | ||
| Socio-demographic variables | Gender | Male |
| Female | ||
| Age | Years old | |
| Final education level | Compulsory education or senior high school | |
| Vocational college or junior college | ||
| 4-year or 6-year university | ||
| Master’s degree | ||
| IBD variables | Type of IBD | Crohn’s Disease |
| Ulcerative Colitis | ||
| Time after the diagnosis of IBD | 0–2 years | |
| 3–8 years | ||
| 9–15 years | ||
| Longer than 15 years | ||
| Comorbidity variables | Hyperlipidemia/dyslipidemia | No |
| Yes | ||
| Hypertension | No | |
| Yes | ||
| Depression | No | |
| Yes | ||
| Treatment variables | Prescription of biologics | No |
| Yes | ||
| Experience of surgical treatment | No | |
| Yes | ||
| Interaction variables | Interaction between biologic and surgical treatment | Surgical treatment with biologics |
| Surgical treatment without biologics | ||
Fig. 1Study population
Characteristics of the IBD patient sample versus the general population in Japan
| Characteristics | Sample analyzed (n) | Sample analyzed (%) | Overall population (%) | Reference | |
|---|---|---|---|---|---|
| Gender | Male | 616 | 73.5% | 48.6% | [ |
| Female | 222 | 26.5% | 51.4% | [ | |
| Age | 20–29 | 53 | 6.3% | 17.4% | [ |
| 30–39 | 210 | 25.1% | 21.8% | [ | |
| 40–49 | 331 | 39.5% | 24.8% | [ | |
| 50–59 | 201 | 24.0% | 20.9% | [ | |
| 60–64 | 43 | 5.1% | 15.1% | [ | |
| Employment rate (Based on 735 employed patients) | 20–29 | 46 | 75.4% | 73.8% | [ |
| 30–39 | 194 | 78.5% | 80.8% | [ | |
| 40–49 | 299 | 78.7% | 83.7% | [ | |
| 50–59 | 173 | 72.7% | 81.1% | [ | |
| 60–64 | 23 | 44.2% | 62.2% | [ | |
| Overall employment rate (age & gender adjusted) | 20–64 | 838 | 75.1% (60.0%) | 78.1% | [ |
| Final education | Compulsory education or senior high school | 221 | 26.4% | 65.6% | [ |
| Vocational college or junior college | 184 | 22.0% | 14.7% | [ | |
| 4-year or 6-year university | 369 | 44.0% | 19.8% | [ | |
| Master’s degree | 64 | 7.6% | [ | ||
| Unemployment | Unemployment rate | 103 | 12.3% | 3.2% | [ |
| IBD type | Crohn’s Disease | 204 | 24.3% | ― | ― |
| Ulcerative Colitis | 634 | 75.7% | ― | ― | |
| Time after the diagnosis of IBD | 0–2 years | 137 | 16.3% | ― | ― |
| 3–8 years | 299 | 35.7% | ― | ― | |
| 9–15 years | 186 | 22.2% | ― | ― | |
| Longer than 15 years | 216 | 25.8% | ― | ― | |
| Comorbidity | Hyperlipidemia/dyslipidemia | 99 | 11.8% | ― | ― |
| Hypertension | 121 | 11.4% | ― | ― | |
| Depression | 57 | 6.8% | ― | ― | |
| Treatment | Prescription of biologics | 148 | 17.7% | ― | ― |
| Stage | Experience of surgical treatment | 202 | 24.1% | ― | ― |
Logistic regression of employment versus unemployment
| Variable | OR of Employment |
| [95% Confidence Interval] |
|---|---|---|---|
| Gender | |||
| Male | (Reference) | ||
| Female | 0.62 | 0.07 | [0.37–1.05] |
| Age | |||
| One additional age | 0.94 | 0.00 | [0.91–0.96] |
| Final education level | |||
| Compulsory or senior high school | (Reference) | ||
| Vocational School | 1.25 | 0.51 | [0.65–2.38] |
| Junior college | 1.11 | 0.80 | [0.48–2.57] |
| 4-year or 6-year university | 2.21 | 0.00 | [1.29–3.80] |
| Master’s degree | 2.95 | 0.06 | [0.97–8.91] |
| Type of IBD | |||
| Crohn’s Disease | (Reference) | ||
| Ulcerative Colitis | 1.95 | 0.03 | [1.06–3.59] |
| Time after the diagnosis of IBD | |||
| 0–2 years | (Reference) | ||
| 3–8 years | 1.75 | 0.12 | [0.86–3.56] |
| 9–15 years | 1.02 | 0.95 | [0.50–2.09] |
| Longer than 15 years | 1.10 | 0.79 | [0.54–2.24] |
| Comorbidity | |||
| Hyperlipidemia/dyslipidemia | 1.31 | 0.52 | [0.58–2.97] |
| Hypertension | 0.74 | 0.38 | [0.38–1.44] |
| Depression | 0.29 | 0.00 | [0.14–0.59] |
| Treatment | |||
| Prescription of biologics | 0.51 | 0.07 | [0.25–1.06] |
| Experience of surgical treatment | 2.44 | 0.08 | [0.90–6.62] |
| Stage | |||
| Interaction | |||
| Experienced surgery | |||
| Surgical treatment with biologics | (Reference) | ||
| Surgical treatment without biologics | 0.38 | 0.09 | [0.12–1.17] |
| Constant term | 59.44 | 0.00 | [8.51–414.94] |
OR, odds ratio